Alternative splicing and cancer: a systematic review.
Zhang Y, Qian J, Gu C, Yang Y. · 2021
Read Alternative splicing and cancer: a systematic review. by Zhang Y, Qian J, Gu C, Yang Y. (2021) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7902610.txt.
Description
Zhang and co-authors present a systematic review of alternative splicing in cancer. Splicing is the step that cuts and rejoins RNA messages before they are read. Faulty splicing can produce abnormal protein forms. Such faults often appear as tumours form and grow. The review sets out how the process works and where it goes wrong.
The authors explain the rules that govern normal splicing choices. They then trace the effects of abnormal splicing on tumour growth, cell death, invasion, and new blood vessel growth. Changes in splicing factors found in tumours get full cover. So do odd splicing events in long non-coding and circular RNAs. The review closes with treatments that target splicing itself. These include drugs that reshape spliced products and immune therapies built on tumour-specific forms.
Catalog record
| CREATOR | Zhang Y, Qian J, Gu C, Yang Y. |
|---|---|
| YEAR | 2021 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 85 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |